Bristol-Myers Squibb (BMY) Tops Q1 EPS by 10c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $54.70 +1.30%
Revenue Growth %: -4.6%
Financial Fact:
Cost of products sold: 1.31B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -4.6%
Financial Fact:
Cost of products sold: 1.31B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $0.84, $0.10 better than the analyst estimate of $0.74. Revenue for the quarter came in at $4.93 billion versus the consensus estimate of $4.72 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2017 EPS of $2.85-$3.00, versus the consensus of $2.80.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Robinhood prices $2B convertible notes offering due 2029
- Sun Communities names Ileana McAlary as general counsel and EVP
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
